![](/img/cover-not-exists.png)
In Re: Re: “Phase II trial of trastuzumab in women with advanced or recurrent HER2-positive endometrial carcinoma: A Gynecologic Oncology Group Study”
Michael W. Sill, Gini FlemingVolume:
118
Year:
2010
Language:
english
Pages:
2
DOI:
10.1016/j.ygyno.2010.03.005
File:
PDF, 71 KB
english, 2010